Cargando…

Vasohibin 2 Decreases the Cisplatin Sensitivity of Hepatocarcinoma Cell Line by Downregulating p53

Hepatocellular carcinoma (HCC) is a prevalent problem worldwide. Chemotherapy, especially cisplatin (CDDP)-based systemic chemotherapy, is the best option for advanced liver cancer. However, CDDP resistance is becoming common and hindering the clinical application of CDDP. Meanwhile, no consensus ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Zhanjun, Tu, Min, Han, Bei, Gu, Yuqing, Xue, Xiaofeng, Sun, Jie, Ge, Qianqian, Miao, Yi, Qian, Zhuyin, Gao, Wentao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942424/ https://www.ncbi.nlm.nih.gov/pubmed/24595063 http://dx.doi.org/10.1371/journal.pone.0090358

Ejemplares similares

Vasohibin-2 promotes proliferation in human breast cancer cells via upregulation of fibroblast growth factor-2 and growth/differentiation factor-15 expression
por: TU, MIN, et al.
Publicado: (2014)

Age‐associated downregulation of vasohibin‐1 in vascular endothelial cells
por: Takeda, Eichi, et al.
Publicado: (2016)

The Vasohibin Family
por: Sato, Yasufumi
Publicado: (2010)

MiR200-upregulated Vasohibin 2 promotes the malignant transformation of tumors by inducing epithelial-mesenchymal transition in hepatocellular carcinoma
por: Xue, Xiaofeng, et al.
Publicado: (2014)

Thioredoxin Downregulation Enhances Sorafenib Effects in Hepatocarcinoma Cells
por: López-Grueso, María José, et al.
Publicado: (2019)

Vasohibin-1 suppresses colon cancer
por: Liu, Shuai, et al.
Publicado: (2015)

Structural basis of tubulin detyrosination by vasohibins
por: Li, Faxiang, et al.
Publicado: (2019)

Enhanced antitumor activity by combining an adenovirus harboring ING4 with cisplatin for hepatocarcinoma cells
por: Xie, Y, et al.
Publicado: (2011)

Metformin enhances the chemosensitivity of hepatocarcinoma cells to cisplatin through AMPK pathway
por: Dong, Hao, et al.
Publicado: (2017)

Downregulation of vasohibin-2, a novel angiogenesis regulator, suppresses tumor growth by inhibiting angiogenesis in endometrial cancer cells
por: KOYANAGI, TAKAHIRO, et al.
Publicado: (2013)

Structural insights into tubulin detyrosination by vasohibins-SVBP complex
por: Liu, Xi, et al.
Publicado: (2019)

Vasohibin 2 reduces chemosensitivity to gemcitabine in pancreatic cancer cells via Jun proto-oncogene dependent transactivation of ribonucleotide reductase regulatory subunit M2
por: Tu, Min, et al.
Publicado: (2017)

Enhanced Cancer Metastasis in Mice Deficient in Vasohibin-1 Gene
por: Ito, Soichi, et al.
Publicado: (2013)

Exacerbation of Diabetic Renal Alterations in Mice Lacking Vasohibin-1
por: Hinamoto, Norikazu, et al.
Publicado: (2014)

Role of the Vasohibin Family in the Regulation of Fetoplacental Vascularization and Syncytiotrophoblast Formation
por: Suenaga, Kaori, et al.
Publicado: (2014)

The prognostic significance of vasohibin-1 expression in patients with prostate cancer
por: Kosaka, T, et al.
Publicado: (2013)

The roles of vasohibin and its family members: Beyond angiogenesis modulators
por: Du, Hua, et al.
Publicado: (2017)

The expression of vasohibin-1 and its prognostic significance in bladder cancer
por: Zhang, Bo, et al.
Publicado: (2017)

Chronic pancreatitis with multiple pseudocysts and pancreatic panniculitis: A case report
por: Gu, Yuqing, et al.
Publicado: (2018)

Double-Face of Vasohibin-1 for the Maintenance of Vascular Homeostasis and Healthy Longevity
por: Sato, Yasufumi
Publicado: (2018)

Vasohibin‐2 plays an essential role in metastasis of pancreatic ductal adenocarcinoma
por: Iida‐Norita, Rie, et al.
Publicado: (2019)

Vasohibin 1 selectively regulates secondary sprouting and lymphangiogenesis in the zebrafish trunk
por: de Oliveira, Marta Bastos, et al.
Publicado: (2021)

Antitumor effect of isoquercetin on tissue vasohibin expression and colon cancer vasculature
por: da Silva, Daniel de Castilho, et al.
Publicado: (2022)

Curcumin Suppresses Hepatic Stellate Cell-Induced Hepatocarcinoma Angiogenesis and Invasion through Downregulating CTGF
por: Shao, Shan, et al.
Publicado: (2019)

Overexpression of sulfatase-1 in murine hepatocarcinoma Hca-F cell line downregulates mesothelin and leads to reduction in lymphatic metastasis, both in vitro and in vivo
por: Mahmoud, Salma, et al.
Publicado: (2016)

δ-Aminolevulinic acid cytotoxic effects on human hepatocarcinoma cell lines
por: De Siervi, Adriana, et al.
Publicado: (2002)

Determination of Perflourooctanoic Acid Toxicity in a Human Hepatocarcinoma Cell Line
por: Abudayyak, Mahmoud, et al.
Publicado: (2021)

PLGA-Loaded Gold-Nanoparticles Precipitated with Quercetin Downregulate HDAC-Akt Activities Controlling Proliferation and Activate p53-ROS Crosstalk to Induce Apoptosis in Hepatocarcinoma Cells
por: Bishayee, Kausik, et al.
Publicado: (2015)

Vasohibin inhibits angiogenic sprouting in vitro and supports vascular maturation processes in vivo
por: Kern, Johann, et al.
Publicado: (2009)

Mutual Balance between Vasohibin-1 and Soluble VEGFR-1 in Endothelial Cells
por: Miyashita, Hiroki, et al.
Publicado: (2011)

Vasohibin-2 modulates tumor onset in the gastrointestinal tract by normalizing tumor angiogenesis
por: Kitahara, Shuji, et al.
Publicado: (2014)

AB262. Expression of vasohibin-1 in prostate cancer and its progress research
por: Zhang, Bo, et al.
Publicado: (2016)

AB035. Vasohibin-1 as a potential therapeutic target for erectile dysfunction
por: Song, Kang-Moon, et al.
Publicado: (2018)

Loss of PRDX6 Aborts Proliferative and Migratory Signaling in Hepatocarcinoma Cell Lines
por: Lagal, Daniel J., et al.
Publicado: (2023)

Vasohibin‐1 deficiency enhances renal fibrosis and inflammation after unilateral ureteral obstruction
por: Watatani, Hiroyuki, et al.
Publicado: (2014)

Vasohibin‐1 expression inhibits advancement of ovarian cancer producing various angiogenic factors
por: Takahashi, Yoshifumi, et al.
Publicado: (2016)

Targeting human vasohibin‐2 by a neutralizing monoclonal antibody for anti‐cancer treatment
por: Koyanagi, Takahiro, et al.
Publicado: (2017)

Genetic Deletion of Vasohibin-2 Exacerbates Ischemia-Reperfusion-Induced Acute Kidney Injury
por: Miyake, Hiromasa, et al.
Publicado: (2020)

Exogenous Vasohibin-2 Exacerbates Angiotensin II-Induced Ascending Aortic Dilation in Mice
por: Okuyama, Michihiro, et al.
Publicado: (2019)

Vasohibin 2 promotes malignant behaviors of pancreatic cancer cells by inducing epithelial‐mesenchymal transition via Hedgehog signaling pathway
por: Zhang, Ye, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0o74udmk3rbfbp5n55g4o30jmf